Hermine Agis

7PUBLICATIONS
43CO-AUTHORS
Regenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 13, 2026
Plerixafor and G-CSF Versus Placebo and G-CSF in Moderately Mobilizing Patients With Multiple Myeloma to Optimize Hematopoietic Stem Cell Collection Results (OPTIMIZE).

|Aug 26, 2026
Real-world outcomes of ide-cel and cilta-cel in relapsed/refractory multiple myeloma: A nationwide, retrospective analysis in Austria.

|Oct 24, 2025
Parameters Associated With Renal Recovery and Survival in Myeloma Patients With Acute Renal Failure to Cast Nephropathy.

Heinz Ludwig, Meletios Athanasios Dimopoulos, Evangelos Terpos

|Jun 19, 2024
QoL during KTd or KRd induction followed by K maintenance or observation in transplant noneligible patients with newly diagnosed multiple myeloma: Longitudinal and cross-sectional analysis of the randomized AGMT 02 study.

Heinz Ludwig, Thomas Melchardt, Ilvy Schweitzer

|Mar 01, 2024
Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma.

Heinz Ludwig, Thomas Melchardt, Siegfried Sormann

|Sep 20, 2022
Deep Morphology Learning Enhances Ex Vivo Drug Profiling-Based Precision Medicine.

Tim Heinemann, Christoph Kornauth, Yannik Severin

Pageof 2

Frequent Collaborators

3 joint publications

Heinz Ludwig

2 joint publications

Worel Nina

2 joint publications

Alexander Egle

1 joint publications

Schreder Martin